Vitamin D supplementation: a comprehensive review on supplementation for tuberculosis prophylaxis

References

• Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 2009;4(9):1151-65
   PubMed Web of Science ®Google Scholar
• Coussens AK, Martineau AR, Wilkinson RJ. Anti-inflammatory and antimicrobial actions of vitamin D in combating TB/HIV. Scientifica (Cairo) 2014;2014:903680
   PubMedGoogle Scholar
• Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc 2012;7(1):50-61
   Google Scholar
• Fabri M, Stenger S, Shin DM, et al. Vitamin D Is Required for IFN-γ–mediated antimicrobial activity of human macrophages. Sci Transl Med 2011;3(104):104ra102
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80(6 Suppl):1717S-20S
   PubMed Web of Science ®Google Scholar
• Campbell GR, Spector SA. Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy 2012;8(10):1523-5
   PubMed Web of Science ®Google Scholar
• Ho-Pham LT, Nguyen ND, Nguyen TT, et al. Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infect Dis 2010;10:306
   PubMedGoogle Scholar
• Chun RF, Liu PT, Modlin RL, et al. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol 2014;5:151
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311(5768):1770-3
   PubMed Web of Science ®Google Scholar
• Shin DM, Yuk JM, Lee HM, et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol 2010;12(11):1648-65
   PubMed Web of Science ®Google Scholar
• Sato E, Imafuku S, Ishii K, et al. Vitamin D-dependent cathelicidin inhibits Mycobacterium marinum infection in human monocytic cells. J Dermatol Sci 2013;70(3):166-72
   PubMedGoogle Scholar
• Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Feder Am Soc Exp Biol 2005;19(9):1067-77
   PubMed Web of Science ®Google Scholar
• Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009;6(3):231-43
   PubMed Web of Science ®Google Scholar
• Jo EK, Do M. Infection signaling network research center CNUSoM, 6 Munhwa-dong, Jungku, Daejeon 301-747, Korea. Innate immunity to mycobacteria: vitamin D and autophagy. Cell Microbiol 2014;12(8):1026-35
   Google Scholar
• Dini C, Bianchi A. The potential role of vitamin D for prevention and treatment of tuberculosis and infectious diseases. Ann Ist Super Sanità 2012;48(3):319-27
   PubMedGoogle Scholar
• Liu PT, Stenger S, Tang DH, et al. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007;179(4):2060-3
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson KA, Newton SM, et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007;178(11):7190-8
   PubMed Web of Science ®Google Scholar
• Fabri M, Stenger S, Shin DM, et al. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011;3(104):104ra102
   PubMed Web of Science ®Google Scholar
• Rivas-Santiago CE, Hernandez-Pando R, Rivas-Santiago B. Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers. Immunotherapy 2013;5(10):1117-26
   PubMedGoogle Scholar
• Chan TY. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int 2000;66(6):476-8
   PubMedGoogle Scholar
• Chun RF, Adams JS, Hewison M. Immunomodulation by vitamin D: implications for TB. Expert Rev Clin Pharmacol 2011;4(5):583-91
   PubMedGoogle Scholar
• Afsal K, Harishankar M, Banurekha VV, et al. Effect of 1,25-dihydroxy vitamin D on cathelicidin expression in patients with and without cavitary tuberculosis. Tuberculosis (Edinb) 2014;94(6):599-605
   PubMedGoogle Scholar
• Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011;377(9761):242-50
   PubMed Web of Science ®Google Scholar
• Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009;179(9):843-50
   PubMed Web of Science ®Google Scholar
• Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006;38(1):3-5
   PubMedGoogle Scholar
• Kota SK, Jammula S, Tripathy PR, et al. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metab Syndr 2011;5(2):85-9
   PubMedGoogle Scholar
• Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012;109(38):15449-54
   PubMed Web of Science ®Google Scholar
• Morcos MM, Gabr AA, Samuel S, et al. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 1998;137(5):157-64
   PubMedGoogle Scholar
• Mily A, Rekha RS, Kamal SM, et al. Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis. BMC Pulm Med 2013;13:23
   PubMed Web of Science ®Google Scholar
• Talat N, Perry S, Parsonnet J, et al.Vitamin D. Deficiency and Tuberculosis Progression. Emerg Infect Dis 2010;16(5):853-5
   PubMed Web of Science ®Google Scholar
• Williams B, Williams AJ, Anderson ST. Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J 2008;27(10):941-2
   PubMedGoogle Scholar
• Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 2010;104(10):1487-91
   PubMedGoogle Scholar
• Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008;37(1):113-19
   PubMed Web of Science ®Google Scholar
• Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008;46(3):443-6
   PubMed Web of Science ®Google Scholar
• Lopez-Lopez N, Gonzalez-Curiel I, Castaneda-Delgado J, et al. Vitamin D supplementation promotes macrophages’ anti-mycobacterial activity in type 2 diabetes mellitus patients with low vitamin D receptor expression. Microbes Infect 2014;16(9):755-61
   PubMedGoogle Scholar
• Vieth R. Vitamin D nutrient to treat TB begs the prevention question. Lancet 2011;377(9761):189-90
   PubMedGoogle Scholar
• Martineau AR. Trial of vitamin D supplementation to prevent acquisition of latent tuberculosis infection in schoolchildren. Blizard Institute, Barts and the London School of Medicine and Dentistry. Available from: http://blizard.qmul.ac.uk/research-generation/869-vidikids.html
   Google Scholar
• Davaasambuu, Ganmaa, Professor A. Vitamin D supplementation in TB Prevention. In: Clinical Trials.gov. Available from: https://clinicaltrials.gov/show/NCT02276755
   Google Scholar
• Davaasambuu G, Giovannucci E, Bloom BR, et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr 2012;96(2):391-6
   PubMedGoogle Scholar
• Arnedo-Pena A, Juan-Cerdan JV, Romeu-Garcia A, et al. Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infect Dis 2011;11:349
   PubMedGoogle Scholar
• Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176(2):208-13
   PubMed Web of Science ®Google Scholar
• Larcombe L, Orr P, Turner-Brannen E, et al. Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dene First Nations cohort. PLoS One 2012;7(7):e40692
   Google Scholar
• Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96(1):53-8
   PubMed Web of Science ®Google Scholar
• Yamshchikov AV, Desai NS, Blumberg HM, et al. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009;15(5):438-49
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang P, Ni X, et al. Vitamin D status in chronic dialysis patients with depression: a prospective study. BMC Psychiatry 2014;125
   Google Scholar
• Lewis SJ, Baker I, Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis 2005;9(10):1174-7
   PubMed Web of Science ®Google Scholar
• Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000;355(9204):618-21
   PubMed Web of Science ®Google Scholar
• Ross C, Taylor CL, Yaktine AL, et al. Tolerable Upper Intake Levels: Calcium and Vitamin D (National Academies Press (US), Institute of Medicine (US) committee to review dietary reference intakes for vitamin D and calcium. 2011
   Google Scholar
• Marcus JF, Shalev SM, Harris CA, et al. Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution. Arch Neurol 2012;69(1):129-32
   PubMedGoogle Scholar
• Compston JE. Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk. BMJ 1998;317(7171):1466-7
   PubMedGoogle Scholar